Strong growth anticipation may have inflated P/E ratio yet inconsistent recent earnings cast doubt on its sustainability. Current stock prices may not be sustainable as recent trends could affect share price.
A rise in insider selling at Aehr Test Systems signals caution for shareholders. Despite its profitability and growth, the low level of insider ownership raises concerns. Current insider trends suggest it might not be an ideal investment choice.
Pre-Market Stock Movers Gapping up $パイオニア ナチュラル リソーシーズ(PXD.US)$soared nearly 10% in premarket trading after The Wall Street Journal reported Pioneer was close to reaching a deal to be bought by Exxon Mobil for about $60 billion. Shares of Exxon were down 3%. $アペリス・ファーマシューティカルズ(APLS.US)$Shares rose 5.5% after Apellis reported growing sales for its Syfovre drug in August. JPMorgan upgraded the stock to ov...
Summary: 1. Aehr Test Systems reported record financial performance in Q4 and fiscal year 2023 with revenue increasing by 28% YoY to $65 million. 2. The company generated a record $10 million in operating cash flow in fiscal 2023, up more than 500% from the prior year, and expects full year total revenue to be at least $100 million in fiscal 2024, representing growth of over 50% YoY. 3. Aehr's strong financial position includes a c...
エア・テスト・システムズに関するコメント
$AEHR Support / Resistance Levels
Larger Image: tradingview.com...
$エア・テスト・システムズ(AEHR.US)$
🚀🚀🚀🚀🚀🚀
📊⚡️📊
コラムToday's Pre-Market Stock Movers and Top Ratings: TSLA, LEVI, PXD, APLS and More
Gapping up
$パイオニア ナチュラル リソーシーズ(PXD.US)$ soared nearly 10% in premarket trading after The Wall Street Journal reported Pioneer was close to reaching a deal to be bought by Exxon Mobil for about $60 billion. Shares of Exxon were down 3%.
$アペリス・ファーマシューティカルズ(APLS.US)$ Shares rose 5.5% after Apellis reported growing sales for its Syfovre drug in August. JPMorgan upgraded the stock to ov...
コラムAehr Test Systems (AEHR) Q4 2023 Earnings Call Transcript Summary
1. Aehr Test Systems reported record financial performance in Q4 and fiscal year 2023 with revenue increasing by 28% YoY to $65 million.
2. The company generated a record $10 million in operating cash flow in fiscal 2023, up more than 500% from the prior year, and expects full year total revenue to be at least $100 million in fiscal 2024, representing growth of over 50% YoY.
3. Aehr's strong financial position includes a c...
silicon carbide
good earning. fly high to the moon
まだコメントはありません